疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

. v" G* ]7 @7 I' ?

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.
7 P( M. A: `8 W5 f6 L% v+ B
. ~& S$ |. |' e& Chttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

# k6 p) H( y. A, |4 ^SECTION 1: General aspects of vaccination
3 M3 c1 |0 h# V1 d4 R" R! M1 A short history of vaccination 1
: V6 c; Y; f) T. [3 m2 z2 Vaccine immunology 14
3 The vaccine industry 33
  E+ I/ m! d/ P, ~7 [5 _4 Vaccine manufacturing 44
5 Evolution of adjuvants across the centuries 58
/ ~- B- \" c4 M8 c4 a: P6 Vaccine additives and manufacturing residuals in the United States:
7 \7 b) D7 a- Wlicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
% {3 d3 u2 g" y5 H! _, y* E8 R. QSECTION 2: Licensed vaccines
6 m$ v$ a3 C; y9 Adenovirus vaccines 113
- I% J. j3 ]5 _  o+ s8 p1 f10 Anthrax vaccines 127
11 Cholera vaccines 141
/ R! `1 \/ J. p12 Diphtheria toxoid 153
9 U2 s& u3 Y0 ?; q7 I5 o13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
5 r' O& z9 e/ P9 Z16 Human papillomavirus vaccines 235
: x( o5 p. Q& X, s$ Y4 v17 Inactivated influenza vaccines 257
* N3 z3 z& m5 b- E9 d, ~/ B18 Influenza vaccine-live 294
# ^+ r% n  |$ V, Q1 k, N19 Japanese encephalitis vaccines 312
4 ^: r8 X! S4 X20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
% _# ?+ `/ d! @- d; {23 Pertussis vaccines . 447
24 Plague vaccines 493
2 X7 e( l. J  e9 w( I5 c+ z4 z' u  E8 Q4 d25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
: w4 F3 L: m7 j' ^. v3 x& Y) _27 Poliovirus vaccine-inactivated . 573
0 U( I8 i: x& S- r' a# d9 n7 |: T28 Poliovirus vaccine-live 598
4 {4 |' K, U; E29 Rabies vaccines .646
3 j* w  ~# X2 h( H0 A30 Rotavirus vaccines . 669
31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
- r# z# h0 K  `7 y% b1 P35 Tuberculosis vaccines 789
) N; B, b; t0 `# N36 Typhoid fever vaccines 812
37 Varicella vaccine 837
# A8 L# o: ?( @1 D38 Yellow fever vaccine 870
/ V8 P3 Y/ A# D# v6 p39 Zoster vaccine 969
& U8 G4 \2 v) D: k4 _0 m40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
. s9 e) g2 l# I  e( V42 Therapeutic cancer vaccines 1018
" T, _3 [1 w( H$ [' [" G43 Cytomegalovirus vaccines 1032
! B$ b6 J, `  G! H) |' b5 N44 Dengue vaccines 1042
' ?0 J* B2 ?1 n' g+ z4 ?45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
4 l- I- b% N& D7 y1 Y47 Epstein-Barr virus vaccines 1068
48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
9 L  y  \$ r: X6 F8 J52 Lyme disease vaccines 1122
0 {3 ^& h+ F5 \! c53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
* B3 [/ u5 D7 Q3 x8 ]3 ?9 w$ f55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
8 S  ^0 V. t  K1 I9 t: N57 Staphylococcus aureus vaccines 1161
6 j0 y) C6 ]! e* i58 Streptococcus group A vaccines 1169
/ m6 T  C; _/ L4 N2 ~' E6 |& ~59 Streptococcus group B vaccines 1176
; u$ A7 U0 k1 g! I60 Technologies for making new vaccines 1182
8 c2 h. B+ T/ E- T# H& P7 m$ C61 Alternative vaccine delivery methods 1200
" N9 v5 F" Z8 o9 {9 [1 l. K62 The development of gene-based vectors for immunization 1232
( Q' J/ k) c' t- r: ?SECTION 4: Vaccination of special groups
! U/ O7 N2 ^( ?63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
# R5 f( G; p2 c' j65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
( L6 n/ t% K( F4 mSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
. f2 z# C  F0 j$ q. ?7 V2 I69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
71 Community immunity 1395
( Z5 v1 c- c9 P/ w& A. f72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
; D  U3 i4 N! Y. h: X75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
5 Q  Y  y) E: C) j8 J2 F$ C  x77 Legal issues . 1481
$ x8 N5 ?' _, A* C7 x' ~) r) c7 \+ e78 Ethics 1508




# u$ q; M. E5 L+ g8 U- h* B  q

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition

8 Z) M& T& u. [! ]7 n0 MApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

2 X% D9 w! N: Yhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
" \8 h# S8 V/ Y$ c
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
+ |- O. h% b& \' j2 e4 Vaccine manufacturing 44
  ^0 W$ m! J: U5 Evolution of adjuvants across the centuries 58
. r& s: l$ M$ g6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
. x0 @* D$ ]7 J7 Passive immunization 80
8 General immunization practices 88
7 W( u5 \* {  O  B! `+ \- ]SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
2 Y8 B9 b# n3 W% P10 Anthrax vaccines 127
11 Cholera vaccines 141
* v. \, ~7 P) r12 Diphtheria toxoid 153
% ^; [# l2 O6 x+ {13 Haemophilus influenzae vaccines 167
6 P3 j) r5 {5 H# y1 z14 Hepatitis A vaccines 183
; ]4 Z1 [4 f' g15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
' X! k  Z' p: M/ L1 b# ]17 Inactivated influenza vaccines 257
2 R% X0 A- N  U; ~+ @* X9 k18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
; A/ H$ b' I3 Q! W3 X+ y20 Measles vaccines 352
! e" W0 r  M& p* N2 e' k5 D21 Meningococcal vaccines 388
. @; V& i. c2 J5 T22 Mumps vaccine 419
2 N- M5 x) Q: e1 m5 ?$ U6 M; F23 Pertussis vaccines . 447
1 n' a; X  L+ k$ A! u, U24 Plague vaccines 493
, k- X  ]1 r& W: N/ e6 l9 a% D8 G25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
( ]& t& n6 n, K, L26 Pneumococcal polysaccharide vaccines 542
  P! K9 |9 ?3 I, g8 x27 Poliovirus vaccine-inactivated . 573
- |, [! T8 u' V28 Poliovirus vaccine-live 598
29 Rabies vaccines .646
30 Rotavirus vaccines . 669
; P1 T1 Y8 z5 ]9 P  j31 Rubella vaccine 688
32 Smallpox and vaccinia 718
2 J! q0 w9 f) K2 d( I4 a33 Tetanus toxoid 746
( d1 q# ^# Y( u  E$ O$ A34 Tick-borne encephalitis virus vaccines 773
% u9 k0 ^: G& D, C35 Tuberculosis vaccines 789
, ?1 F( f: b1 f9 U1 K3 `9 I36 Typhoid fever vaccines 812
37 Varicella vaccine 837
/ w/ Z( R8 U- ^: [' M8 `38 Yellow fever vaccine 870
7 I+ ]1 d3 D3 c- T$ I1 @3 p% v  v39 Zoster vaccine 969
40 Combination vaccines 981
) ^' K  A2 Q* i9 VSECTION 3: Vaccines in development and new vaccine strategies
: ]6 H  U" `+ P9 f# K41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
7 Q5 F4 l1 e* L# ?+ K4 N3 G45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
9 A0 M/ j- }) m' T48 Hepatitis C vaccines 1074
6 F( H: @$ W5 p49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
, f- Q: Q3 r2 Q) g# i2 S55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
" B$ G! _6 E. t) I57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
60 Technologies for making new vaccines 1182
9 H  A; y; i- J! \6 w( N61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
# `2 B  s7 _0 }# p5 P: c2 RSECTION 4: Vaccination of special groups
! D& C' T7 C( y1 z9 l63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
. b! A: @& ?( T$ Q; s, [66 Vaccines for health care personnel 1290
3 p; A. D0 m$ ~SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
6 F9 K0 D1 z- K( G1 w68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
. {* Y7 E* O# T6 L! O: y9 }# ^70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
8 V; I$ @4 ^4 d  y. V8 X* z8 T; k75 Regulation of vaccines in developing countries 1454
; E& I& O4 R4 t  V76 Vaccine safety 1464
77 Legal issues . 1481
8 A6 A; V( u& b+ D' H1 a78 Ethics 1508


% f7 e9 a3 R0 |- U6 g( i6 h5 R

casarett

Vaccines, 6e, 2012
) ^: C/ q8 ], S: b4 t- t
Hardcover: 1570 pages
. T9 x* F  y0 f3 X, ~7 Q; JPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
ISBN-10: 1455700908
1 b! |( B6 v; {# I/ I- YSize: 52.3mb (original pdf)

( l$ v7 a* i! p4 l! l2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
" D/ w, S( l: ]( y) p5 H9 U1 uClearly visualize concepts and objective data through an abundance of tables and figures.
- N$ [, v. O6 B: k/ c5 O8 O4 XPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
Make optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
# H  h- ?4 o/ x7 x/ V' M. xStay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
# O% q4 U, D9 x+ [# X
7 d% ]( R% M3 @$ q# r5 YDownload link: http://pan.baidu.com/s/1i5NxwLR
# f3 T# m, L5 m. F6 YCode for downloading: dv96